# Autoimmune fibroinflammation in IgG4-related ophthalmic disease: TLR8-dependent signaling pathways and fibrotic remodeling revealed by proteomic profiling

**Authors:** Yingxue Ma, Dejuan Song, Chuanjie Xu, GuangYu Li

PMC · DOI: 10.3389/fimmu.2026.1669568 · 2026-01-28

## TL;DR

This study identifies TLR8-dependent pathways and fibrosis markers in IgG4-related ophthalmic disease using proteomic analysis of lacrimal gland tissue.

## Contribution

Novel proteomic profiling reveals TLR8 signaling and fibrotic markers in IgG4-ROD, offering potential diagnostic and therapeutic targets.

## Key findings

- Patients with suspected IgG4-ROD share proteomic profiles with diagnosed cases, suggesting a common disease population.
- Diagnosed IgG4-ROD cases show severe fibrosis and reduced lacrimal secretion function compared to controls.
- TLR8-related proteins are upregulated, implicating TLR signaling in disease pathogenesis.

## Abstract

Immunoglobulin G4-related ophthalmic disease (IgG4-ROD) is an immune-mediated ocular condition characterized by tumefactive lesions with IgG4+ plasma cell infiltration, and commonly affecting the lacrimal gland, extraocular muscles, and trigeminal nerves.The precise pathogenesis of IgG4-ROD remains unclear. Elucidating its molecular mechanisms is crucial for the development of targeted molecular therapies.

To investigate the molecular pathogenesis of IgG4-ROD, we conducted a case-controlled study involving 15 patients who presented at the Second Hospital of Jilin University between 2021 and 2022. In accordance with the comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD) established in 2011, participants were stratified into three distinct cohorts based on lacrimal gland histopathological findings: confirmed IgG4-ROD, suspected IgG4-ROD, and a control group. We then utilized 4D-Fast DIA technology to acquire proteomic profiles from the lacrimal gland biopsies, with rigorous bioinformatics methodologies employed to process and interpret these data, focusing on the differential protein expression patterns across the groups, aiming to identify signaling pathways that are significantly associated with IgG4-ROD.

The comparative analysis of clinical characteristics, imaging features, and histopathological findings among the control group, patients with suspected IgG4-ROD, and diagnosed patients revealed a progressive trend towards more severe pathology. Principal component analysis (PCA) and Pearson correlation heatmaps indicated that the profiles of differentially expressed proteins in lacrimal gland samples from the suspected and diagnosed groups were highly similar, suggesting that the patients from these two groups may belong to the same population. Further analysis of protein expression changes across the three groups revealed significant enrichment in pathways related to asthma, Th1 and Th2 cell differentiation, and other relevant signaling pathways. Notably, Toll-like receptor (TLR), NF-κB, Wnt, and PI3K-AKT signaling pathways were prominently activated. In the diagnosed group, proteins such as MMP7, POSTN, and CD163 exhibited characteristic high-level expression. Furthermore, compared with the suspected group, the diagnosed group showed significant downregulation of proteins related to elastin fibers, indicating a more severe degree of fibrosis in the lacrimal gland tissues. Additionally, the diagnosed group exhibited a significant decrease in proteins associated with lacrimal secretion, suggesting impaired function of lacrimal gland. We also observed a notable upregulation of TLR-8-related proteins in both the suspected and diagnosed groups, implying that the TLR signaling pathway may be closely related to this disease.

Proteomic analysis of lacrimal gland samples from the diagnosed, suspected, and control groups suggests that patients with suspected IgG4-ROD may be part of the same population as diagnosed patients. In the diagnosed group, the lacrimal gland tissue displayed more severe fibrosis and a significant loss of lacrimal secretion function. This study postulates that the TLR - 8/IRAK4/NF - κB pathway may contribute to the molecular pathogenesis of IgG4 - ROD by promoting tissue fibrosis. Proteins such as MMP7, POSTN, and CD163 could potentially serve as molecular markers for the early diagnosis and potential therapeutic targets of IgG4 - ROD. Based on these findings, proteomics offers significant advantages in the molecular diagnosis of IgG4 - ROD and should be regarded as a crucial tool in the diagnosis of this disease.

Diagram illustrating a research workflow analyzing lacrimal gland tissue samples from DG, SG, and CG groups. Steps include tissue sampling, protein extraction, and trypsin digestion, followed by mass spectrometry for protein identification. Statistical analysis highlights MMP7, CD163, and the TLR signaling pathway. Visual heat maps display TLR8 protein expression. Immunohistochemistry further examines MMP7, CD163, and TLR8. The biological pathway involves endosome-related proteins, fibrosis, and an inflammatory microenvironment with cytokines like IL-33 and IL-1β. It also includes immune responses via Th2 and Th17 cells, B lymphocytes, and antibodies IgG4 and IgE.

## Linked entities

- **Proteins:** MMP7 (matrix metallopeptidase 7), POSTN (periostin), CD163 (CD163 molecule), TLR8 (toll like receptor 8), IRAK4 (interleukin 1 receptor associated kinase 4), NFKB1 (nuclear factor kappa B subunit 1)
- **Diseases:** asthma (MONDO:0004979)

## Full-text entities

- **Genes:** MMP7 (matrix metallopeptidase 7) [NCBI Gene 4316] {aka MMP-7, MPSL1, PUMP-1}, POSTN (periostin) [NCBI Gene 10631] {aka OSF-2, OSF2, PDLPOSTN, PN}, TLR8 (toll like receptor 8) [NCBI Gene 51311] {aka CD288, IMD98, TLR-8, hTLR8}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, ELN (elastin) [NCBI Gene 2006] {aka ADCL1, SVAS, WBS, WS}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, IRAK4 (interleukin 1 receptor associated kinase 4) [NCBI Gene 51135] {aka IMD67, IPD1, IRAK-4, NY-REN-64, REN64}, CD163 (CD163 molecule) [NCBI Gene 9332] {aka M130, MM130, SCARI1}
- **Diseases:** IgG4 - ROD (MESH:D000077733), fibrosis (MESH:D005355), condition (MESH:D020763), asthma (MESH:D001249), Autoimmune fibroinflammation (MESH:D001327)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12891096/full.md

---
Source: https://tomesphere.com/paper/PMC12891096